top of page
Microbiome drug development: 2022 in review
Our report covers the most significant news and highlights over the last 12 months in the field of microbiome therapeutics, including regulatory approvals, notable deals, mergers, and acquisitions both between microbiome biotechs and large corporations, a complete financial analysis and key scientific research highlights by area.
Download our report here!
bottom of page